Trial Profile
A Multicentre, Comparative, Two-arm, Parallel-group, Double-blind, Randomized Phase III Study to Assess Immunogenicity and Safety of LBVH0101 (Haemophilus Influenzae Type b Tetanus Toxoid Conjugate Vaccine) Compared With Hiberix Vaccine in Healthy Infants at Two, Four and Six Months of Age.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Jan 2012
Price :
$35
*
At a glance
- Drugs Hib vaccine conjugate (Euhib) (Primary)
- Indications Haemophilus infections
- Focus Pharmacodynamics; Registrational
- Sponsors LG Life Sciences
- 12 Jan 2012 Results published in Vaccine.
- 25 Dec 2009 New trial record
- 25 Dec 2009 New trial record